17 results
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... or colonizing syndromes ... #pharmacology # ... dosing #medications ... #IDSA #Guidelines
Bisphosphonates for Osteoporosis Treatment or Prevention 

Bisphosphonates are common medications used in the treatment and prevention
for Osteoporosis Treatment ... used in the treatment ... Schedule #Frequency #Pharmacology ... #Endocrinology ... #Osteoporosis #Management
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
steroids to treat infectious ... respiratory distress syndrome ... #Pharmacology # ... Management #Treatment ... #Indications
Management of Serotonin Syndrome
Identify and stop all serotoninergic medications
 • Avoid inadvertent Rx of serotoninergic meds
Syndrome Identify ... serotoninergic medications ... serotoninergic meds ... • Dosing: 12mg loading ... #Management #treatment
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... best prevented by using ... ., concomitant medications ... #management #opportunistic ... #pharmacology
Checklist for Treatment of Delirium in the ICU 

Remove causative factors 
 - 
Exclude hypoglycemia if
Checklist for Treatment ... - Review the medication ... c deliriogenic meds ... sleeping, administer pharmacologic ... Delirium #Checklist #Management
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... are contacts of infectious ... Tuberculosis #MDRTB #management ... #regimens #pharmacology ... #dosing #idsa #
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... #Prevention #Treatment ... opportunistic #infections ... #HIVAIDS #management ... pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... patients to take meds ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Preeclampsia, Eclampsia, Infection ... Diagnosis: • Infection ... Electrolyte abnormality, Medication ... epilepticus Treatment ... #diagnosis #management